EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Updated Immunotherapy for Gastric Cancer

Yukiya Narita iD, Kei Muro iD

Journal of Clinical Medicine · 01.04.2023 · 12 (7) · 2636

DOI: 10.3390/jcm12072636 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.04.2023. Verfasst von Yukiya Narita und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer treatments are evolving rapidly. For example, immune checkpoint inhibitors, especially those that target PD-1 or PD-L1, have long-term efficacy in a subset of gastric cancer patients, and are currently the first-line therapy. Immunotherapies approved for use in untreated gastric cancer patients include monotherapy and chemotherapy-immunotherapy combinations. Major clinical trials have reported efficacy and safety data suggesting that PD-L1 expression is important for regimen selection, although other biomarkers, clinicopathologic factors, and patient preference might also be relevant in other situations. Currently, several novel biomarkers and therapeutic strategies are being assessed, which might refine the current treatment paradigm. In this review, we describe the current treatment regimens for patients with gastric cancer and detail the approach we use for the selection of first-line immunotherapy regimens.

Schlagwörter

Stichwörter der Autor:innen

chemotherapygastric cancerimmune checkpoint inhibitorprogrammed cell death 1

Autor:innen und Institutionen

  • Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

ORCID-Profile: Yukiya Narita, Kei Muro

Zitieren

APA

Narita, Y., & Muro, K. (2023). Updated Immunotherapy for Gastric Cancer. Journal of Clinical Medicine, 12(7), 2636. https://doi.org/10.3390/jcm12072636

Vancouver

Narita Y, Muro K. Updated Immunotherapy for Gastric Cancer. Journal of Clinical Medicine. 2023;12(7):2636. doi:10.3390/jcm12072636

BibTeX
@article{Narita2023,
  author = {Narita, Yukiya and Muro, Kei},
  title = {Updated Immunotherapy for Gastric Cancer},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {2636},
  doi = {10.3390/jcm12072636}
}
Kostenlos starten →